SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000891092-07-001915
Filing Date
2007-05-15
Accepted
2007-05-15 15:36:22
Documents
5
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e27320_10q.htm 10-Q 183869
2 CERTIFICATION e27320ex31_1.htm EX-31.1 8899
3 CERTIFICATION e27320ex31_2.htm EX-31.2 8932
4 CERTIFICATION e27320ex32_1.htm EX-32.1 3400
5 CERTIFICATION e27320ex32_2.htm EX-32.2 3405
  Complete submission text file 0000891092-07-001915.txt   210162
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 07852751
SIC: 2836 Biological Products, (No Diagnostic Substances)